Oramed Pharmaceuticals Current Ratio 2011-2018 | ORMP

Oramed Pharmaceuticals current ratio from 2011 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Oramed Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-11-30 $0.03B $0.00B 7.12
2018-08-31 $0.03B $0.01B 6.82
2018-05-31 $0.02B $0.01B 4.18
2018-02-28 $0.02B $0.01B 4.48
2017-11-30 $0.02B $0.01B 3.73
2017-08-31 $0.02B $0.01B 3.93
2017-05-31 $0.03B $0.01B 5.23
2017-02-28 $0.03B $0.01B 6.04
2016-11-30 $0.03B $0.01B 6.44
2016-08-31 $0.03B $0.00B 8.63
2016-05-31 $0.03B $0.00B 18.79
2016-02-29 $0.03B $0.00B 17.14
2015-11-30 $0.02B $0.00B 11.65
2015-08-31 $0.02B $0.00B 11.67
2015-05-31 $0.02B $0.00B 22.62
2015-02-28 $0.02B $0.00B 30.24
2014-11-30 $0.03B $0.00B 29.67
2014-08-31 $0.02B $0.00B 22.38
2014-05-31 $0.02B $0.00B 32.26
2014-02-28 $0.02B $0.00B 67.72
2013-11-30 $0.01B $0.00B 11.95
2013-08-31 $0.01B $0.00B 17.36
2013-05-31 $0.01B $0.00B 10.82
2013-02-28 $0.01B $0.00B 12.65
2012-12-31 $0.00B $0.00B 0.00
2012-11-30 $0.01B $0.00B 20.35
2012-08-31 $0.01B $0.00B 8.19
2012-05-31 $0.00B $0.00B 6.91
2012-02-29 $0.00B $0.00B 5.34
2011-11-30 $0.00B $0.00B 9.11
2011-08-31 $0.00B $0.00B 9.71
2011-05-31 $0.00B $0.00B 0.00
2011-02-28 $0.00B $0.00B 0.00
2010-11-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.056B $0.002B
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.272B 27.73
Medtronic (MDT) Ireland $125.787B 18.39
Stryker (SYK) United States $72.312B 26.54
Boston Scientific (BSX) United States $55.730B 27.17
Baxter (BAX) United States $39.435B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.742B 16.48
Smith & Nephew SNATS (SNN) United Kingdom $17.346B 0.00
Canopy Growth (CGC) Canada $15.357B 0.00
ResMed (RMD) United States $14.383B 27.27
Aurora Cannabis (ACB) Canada $9.728B 68.64
Bio-Rad Laboratories (BIO) United States $9.298B 53.05
Hill-Rom Holdings (HRC) United States $6.949B 21.49
Perrigo (PRGO) Ireland $6.542B 10.61
Insulet (PODD) United States $5.812B 1960.80
GW Pharmaceuticals (GWPH) United Kingdom $5.107B 0.00
ICU Medical (ICUI) United States $4.771B 29.70
Haemonetics (HAE) United States $4.422B 39.23
Agios Pharmaceuticals (AGIO) United States $3.796B 0.00
Hutchison China MediTech (HCM) China $3.712B 0.00
Neogen (NEOG) United States $3.240B 49.77
NuVasive (NUVA) United States $2.859B 24.94
Quidel (QDEL) United States $2.688B 24.25
Aphria (APHA) $2.403B 106.67
National Vision Holdings (EYE) United States $2.385B 46.92
Cardiovascular Systems (CSII) United States $1.382B 992.25
Phibro Animal Health (PAHC) United States $1.275B 18.33
VAREX IMAGING (VREX) United States $1.255B 24.57
AtriCure (ATRC) United States $1.121B 0.00
MacroGenics (MGNX) United States $0.933B 0.00
Lantheus Holdings (LNTH) United States $0.929B 25.10
NanoString Technologies (NSTG) United States $0.855B 0.00
Cerus (CERS) United States $0.838B 0.00
PetIQ (PETQ) United States $0.787B 22.53
Omeros (OMER) United States $0.786B 0.00
OraSure Technologies (OSUR) United States $0.721B 31.62
Surmodics (SRDX) United States $0.703B 102.18
Meridian Bioscience (VIVO) United States $0.701B 20.89
Evolus (EOLS) United States $0.677B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 22.28
LeMaitre Vascular (LMAT) United States $0.614B 29.22
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.552B 0.00
BioLife Solutions (BLFS) United States $0.346B 143.85
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.323B 21.01
Insys Therapeutics (INSY) United States $0.308B 0.00
Owens & Minor (OMI) United States $0.301B 4.17
Rockwell Medical (RMTI) United States $0.297B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.269B 0.00
Bovie Medical (APYX) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Fonar (FONR) United States $0.146B 7.81
Zynex (ZYXI) United States $0.142B 15.14
Surface Oncology (SURF) United States $0.131B 0.00
Chimerix (CMRX) United States $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 18.64
Conatus Pharmaceuticals (CNAT) United States $0.081B 0.00
Trinity Biotech (TRIB) Ireland $0.073B 21.79
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.026B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14